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to the insight this model will provide 
for melanoma, it should also provide 
insight into the complex control of 
melanocytic migration and possibly the 
development of nevi. Kit remains a criti-
cally important regulatory molecule in 
melanocytic biology.
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Functioning Methionine-S-Sulfoxide 
Reductases A and B Are Present in 
Human Skin
Karin U. Schallreuter1,2
Methionine residues in the structure of proteins and peptides are especially sensi-
tive to oxidation by hydrogen peroxide (H2O 2) yielding both the (R) and (S) dia-
stereomers of methionine sulfoxide. This commentary shows that both diastereo-
mers of methionine sulfoxide (R and S) can be repaired in the human epidermis by 
methionine sulfoxide reductases A and B, respectively.
Journal of Investigative Dermatology (2006) 126, 947–949. doi:10.1038/sj.jid.5700086
Several lines of evidence provide sup-
port for the concept that oxidative 
stress causes aging and limits lifespan. 
Therefore, one crucial question arises: 
how does the human epidermis combat 
major oxidative stress–induced protein 
alterations? In this issue, Ogawa et al. 
(2006) describe the discovery of epider-
mal methionine-S-sulfoxide reductase A 
(MSRA), which contributes significantly 
to the presence of oxidative stress repair 
mechanisms in the human skin. Since 
hydrogen peroxide (H2O2) can oxidize 
the sulfur-containing methionine and 
cysteine residues in protein sequences, 
leading to disruption of protein structure 
and, in turn, to dysfunction, this com-
mentary will put the specific problem 
of this reactive oxygen species (ROS)-
mediated damage to proteins and pep-
tides into the context of the repair mech-
anisms involving MSRA and methionine-
S-sulfoxide reductase B (MSRB), both of 
which are essential to salvaging of pro-
tein structure and function as well as to 
cell viability.
ROS oxidation of selective methionine, 
tryptophan, cysteine residues, and 
disulfide bridges in proteins and peptides
The epidermis is especially vulnerable to 
oxidative stress caused by multiple exog-
enous stimuli as well as by a plethora 
of endogenous metabolic events. Many 
mechanisms have been identified in 
controlling the maintenance of the redox 
balance in phase (Nordberg and Arner, 
2001; Schallreuter and Wood, 2001). As 
is pointed out by Ogawa et al. (2006) and 
in earlier work from the same group, skin 
aging is also associated with a decreased 
capacity to neutralize ROS and to repair 
damaged proteins as well as DNA (Thiele 
et al., 1999). In this context Shigenaga 
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and colleagues showed in 1994 that 
mitochondrial stability decreases with 
age owing to lipid peroxidation of mito-
chondrial membranes by ROS, which 
causes the release of cytochrome c from 
the electron transport chain, thus pro-
viding a signal for caspase-mediated 
apoptosis (Shigenaga et al., 1994). Very 
recently the role of ROS in the mitochon-
drion has received a great deal of atten-
tion in the context of aging in mammals, 
and it has been shown that overexpres-
sion of mitochondrial catalase prolongs 
lifespan in mice (Schriner et al., 2005). 
Moreover, reduced expression of MRSA 
decreased the lifespan by 40% in these 
animals, whereas its overexpression in 
Drosophila melanogaster leads to a 70% 
increase. Importantly, thioredoxin reduc-
tase/thioredoxin (TR/T) functions as the 
electron donor for both MSRA and MSRB 
(Kim and Gladyshev, 2004; Neiers et al., 
2004), and overexpression of this system 
increased lifespan by 70% in the murine 
model (Mitsui et al., 2002). A great deal 
about oxidative stress in the human epi-
dermis has been learned from studies of 
the depigmentation disorder vitiligo. The 
epidermis of individuals with vitiligo gen-
erates H2O2, in the concentration range 
of 10–3 M, continuously by various path-
ways leading to deactivation of catalase 
(EC 1.11.1.6), the enzyme that degrades 
this ROS to H2O and O2 (Schallreuter et 
al., 1999). More recently it has become 
clear that other important enzymes and 
proteins are also deactivated by this ROS 
as a result of oxidation of methionine 
residues to methionine sulfoxide in their 
structure. These proteins include dihy-
dropteridine reductase (EC 1.6.99.7), an 
enzyme catalyzing the last step of (6R)-
L-erythro-5,6,7,8-tetrahydrobiopterin 
(6BH4) recycling, as well as acetylcho-
linesterase (EC 3.1.1.7). Deactivation 
also occurs through the oxidation of 
tryptophan residues, as observed in 
4a-pterincarbinolamine dehydratase (EC 
4.2.1.96), whereas oxidation of disul-
fide bridges by peracids greatly alters 
the structure of epidermal albumin (for 
review, see Schallreuter, 2005). Within 
the protein structure, methionine and 
cysteine are the residues most sensitive 
to oxidation by H2O2. This chemical oxi-
dation yields roughly equal concentra-
tions of the two diastereomers, (R) and 
(S), of methionine sulfoxide, resulting in 
the formation of intra- and intercellular 
disulfide bridges, respectively.
MSRA and MSRB in the human epidermis
The purification and determination of  X-
ray crystal structure of both MSRA and 
MSRB have been accomplished during 
the last 5 years and the catalytic mecha-
nisms of action of the two proteins have 
been reported by several groups (Kim and 
Gladyshev, 2004; Neiers et al., 2004). 
MSRA specifically reduces methionine 
sulfoxide (S), whereas MSRB reduces 
methionine sulfoxide (R). Interestingly, 
the increased transcription and activity 
of MSRA by UVA light or by H2O2, as 
reported in this issue, mimics the tran-
scriptional activation of TR (Nordberg 
a
b
Figure 1. MSRA and MSRB are both expressed throughout the human epidermis. (a) In situ 
immunofluorescence of methionine sulfoxide reductases A and B shows partial co-localization of the two 
enzymes. Cryostat sections (5 µm) of human full skin biopsies were fixed in ice-cold methanol (6 min), 
rehydrated in phosphate-buffered saline (PBS) for 30 s, and blocked with normal donkey serum (NDS, 10% 
in PBS) for 90 min, then washed in PBS (5 min). Subsequently, sections were incubated overnight at 4 °C 
with the primary antibody (monoclonal anti-MSRB; mouse, 1:50 in 1% NDS; Autogen Bioclear UK Ltd., 
Calne, UK), washed 3× with PBS, incubated with FITC-labeled secondary antibody (donkey anti-mouse 
IgG, 1:100; Jackson ImmunoResearch Ltd., Soham, UK) for 60 min, washed 4× with PBS and once with 
PBS/Tween, blocked with NDS (10% in PBS) for 90 min, and then washed once in PBS for 5 min. MSRA was 
visualized using polyclonal anti-MSRA antibody (rabbit, 1:50 in 1% NDS; Autogen Bioclear UK Ltd, Calne, 
UK) for 3 h at RT, followed by a 3× wash in PBS, and was incubated with TRITC-labeled secondary antibody 
(donkey anti-rabbit IgG, 1:100; Jackson ImmunoResearch Ltd., Soham, UK) for 60 min, and then washed 
4× with PBS and once with PBS/Tween. Slides were embedded in Vectashield Mounting Medium with 4’,6-
diamino-2-phenylindole (Vector, Peterborough, UK). Fluorescence pictures were taken with a Nikon Eclipse 
80i microscope equipped with ACT-2U software (Nikon UK, Kingston, UK). (b) Western blotting confirmed 
the presence of MSRB (13 kDa calculated) in epidermal undifferentiated and differentiated keratinocyte 
cellular extracts. Proteins from primary epidermal undifferentiated and differentiated keratinocyte cell 
cultures were separated by SDS-PAGE (10%), transferred onto a polyvinylidene difluoride membrane, 
and incubated with the anti-MSRB antibody (1:2,000, overnight at 4 °C), followed by peroxidase-labeled 
antibody (goat anti-mouse IgG, 1:5,000, 1 h at RT; Sigma, Poole, UK). Bands were detected by ECL (Sigma, 
Poole, UK, and Eastman Kodak, Rochester, New York) at the expected size of 13 kDa.
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and Arner, 2001). In this context it is 
fascinating that protein damage caused 
by H2O2-mediated oxidative stress is 
repaired by a system that is upregulated 
at the transcriptional level by this ROS.
However, the presence of epidermal 
MSRA is not sufficient to recover oxidized 
methionines, due to the production of 
both the (R) and the (S) diastereomers of 
methionine sulfoxide by H2O2-mediated 
oxidation. It therefore was not surprising 
to find highly expressed and functional 
MSRB in the epidermal compartment in 
situ as well as in keratinocytes, as shown 
in Figure 1 (K. Rübsam, ongoing medical 
thesis, University of Hamburg). Hence, it 
can be concluded that proteins and pep-
tides damaged as a result of the oxidation 
of methionines in their sequences can be 
totally salvaged by MSRA and MSRB. In 
this context it is noteworthy that both 
TR and the MSRs express cytosolic and 
mitochondrial membrane-integrated iso-
forms, thus maintaining mitochondrial 
as well as cytosolic stability (Hansel et 
al., 2002; Nordberg and Arner, 2001; 
Schallreuter and Wood, 2001).
The importance of epidermal TR/T for 
redox homeostasis
As early as in 1989 it was recognized that 
human epidermal keratinocytes express 
high levels of both cytosolic and mem-
brane-integrated TR. This enzyme is sub-
ject to allosteric inhibition by calcium 
due to a single EF-hands binding site (for 
review see Schallreuter and Wood, 2001). 
Therefore, epidermal calcium homeosta-
sis not only controls differentiation, but 
clearly also controls redox balance. The 
selenoenzyme TR, in addition to being 
the electron donor for both MSRs, this 
selenoenzyme has a very broad speci-
ficity, reducing disulfide bridges, H2O2, 
organoperoxides, vitamin K, and alloxan 
(Nordberg and Arner, 2001).
In summary, the discovery of the 
MSRs in the skin adds yet another 
important role to the epidermal anti-
oxidant repair machinery. Moreover, the 
presence and function of these reduc-
tases imply a functional TR/T system. 
Whether the reductases themselves 
may also be targets for oxidative stress 
remains to be determined.
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"Out, Damned Spot!"
Richard A. Spritz1
Mice transgenic for the Kit Val620Ala mutation, which in humans has been asso-
ciated with progressive piebaldism, exhibit dominant white spotting but show 
no evidence of progressive depigmentation. These results are consistent with 
the previous hypothesis that progressive piebaldism might result from digen-
ic inheritance, of the KITV620A mutation that causes piebaldism and a second, 
unknown locus that causes progressive depigmentation.
Journal of Investigative Dermatology (2006) 126, 949–951. doi:10.1038/sj.jid.5700220
Lady Macbeth’s anguished lament 
speaks to some of the most puzzling 
conundrums in investigative derma-
tology. The white-spotting disorder 
piebaldism, because of its visually 
striking patches of white skin (leuko-
derma) and hair (poliosis), was known 
to the ancient Romans and is thought 
to be the first genetic disorder to have 
been recognized to exhibit autosomal 
dominant inheritance (Morgan, 1786). 
We have learned a lot over the cen-
turies. We now know that the leuko-
dermal patches result from an almost 
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|Skin aging is also associated with a decreased capacity to 
neutralize ROS
